Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT00694057 · COMPLETED

Trial details

NCT number: NCT00694057
Sponsor: Harbor Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2008-06-01
Primary completion: 2010-01-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.